Dandan Feng

Prof. Dandan Feng

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
XHXiao-Ting Huang
Xiao-Ting Huang
CLChen Li
Chen Li
XPXiang-Ping Peng
Xiang-Ping Peng
JGJia Guo
Jia Guo
SYShao-Jie Yue
Shao-Jie Yue
ZLZiqiang Luo
Ziqiang Luo
In the nervous system, excessive activation of NMDA receptors causes neuronal injury. Although activation of NMDARs has been proposed to contribute to the progress of diabetes, little is known about the effect of excessive long-term activation of NMDARs on β-cells, especially under the challenge of hyperglycemia. Here we thoroughly investigated whether endogenous glutamate aggravated β-cell dysfunction under chronic exposure to high-glucoseviaactivation of NMDARs. The glutamate level was increased in plasma of diabetic mice or patients and in the supernatant of β-cell lines after treatment with high-glucose for 72 h. Decomposing the released glutamate improved GSIS of β-cells under chronic high-glucose exposure. Long-term treatment of β-cells with NMDA inhibited cell viability and decreased GSIS. These effects were eliminated byGluN1knockout. The NMDAR antagonist MK-801 orGluN1knockout prevented high-glucose-induced dysfunction in β-cells. MK-801 also decreased the expression of pro-inflammatory cytokines, and inhibited I-κB degradation, ROS generation and NLRP3 inflammasome expression in β-cells exposed to high-glucose. Furthermore, another NMDAR antagonist, Memantine, improved β-cells function in diabetic mice. Taken together, these findings indicate that an increase of glutamate may contribute to the development of diabetes through excessive activation of NMDARs in β-cells, accelerating β-cells dysfunction and apoptosis induced by hyperglycemia.

4 September 2017 in Endocrinology
Verified
Journal Article
Closed access
PDF file
XHXiao-Ting Huang
Xiao-Ting Huang
SYShao-Jie Yue
Shao-Jie Yue
CLChen Li
Chen Li
YHYan-Hong Huang
Yan-Hong Huang
QCQing-Mei Cheng
Qing-Mei Cheng
ZLZiqiang Luo
Ziqiang Luo
Type 2 diabetes, which features β-cell failure, is caused by the decrease of β-cell mass and insulin secretory function. Current treatments fail to halt the decrease of functional β-cell mass. Strategies to prevent β-cell apoptosis and dysfunction are highly desirable. Recently, our group and others have reported that blockade of N-methyl-D-aspartate receptors (NMDARs) in the islets has been proposed to prevent the progress of type 2 diabetes through improving β-cell function. It suggests that a sustained activation of the NMDARs may exhibit deleterious effect on β-cells. However, the exact functional impact and mechanism of the sustained NMDAR stimulation on islet β-cells remains unclear. Here, we identify a sustained activation of pancreatic NMDARs as a novel factor of apoptotic β-cell death and function. The sustained treatment with NMDA results in an increase of intracellular [Ca2+] and reactive oxygen species (ROS), subsequently induces mitochondrial membrane potential depolarization and a decrease of oxidative phosphorylation expression, and then impairs the mitochondrial function of β-cells. NMDA specifically induces the mitochondrial-dependent pathway of apoptosis in β-cells through up-regulation of the pro-apoptotic Bim and Bax, and down-regulation of anti-apoptotic Bcl-2. Furthermore, a sustained stimulation of NMDARs impairs β-cell insulin secretion through decrease of Pdx-1 and ATP synthesis. The activation of NF-κB partly contributes to the reduction of Pdx-1 expression induced by overstimulation of NMDARs. In conclusion, we show that the sustained stimulation of NMDARs is a novel mediator of apoptotic signaling and β-cell dysfunction, providing a mechanistic insight into the pathological role of NMDARs activation in diabetes.

1 May 2022 in Endocrine Connections
Verified
Journal Article
Open access
PDF file
JLJiaxi Li
Jiaxi Li
PHPu Huang
Pu Huang
JXJing Xiong
Jing Xiong
XLXinyue Liang
Xinyue Liang
MLMei Li
Mei Li
CCChen Chen
Chen Chen
Objective: Ghrelin regulates body weight, food intake, and blood glucose. It also regulates insulin secretion from pancreatic islet cells. LEAP2 is a newly discovered endogenous ligand of the growth hormone secretagogue’s receptor (GHSR). It not only antagonizes the stimulation of GHSR by ghrelin but also inhibits the constitutive activation of GHSR as an inverse agonist. Type 2 diabetes (T2D) patients have endocrine disorders with metabolic imbalance. Plasma levels of ghrelin and LEAP2 may be changed in obese and T2D patients. However, there is no report yet on circulating LEAP2 levels or ghrelin/LEAP2 ratio in T2D patients. In this study, fasting serum ghrelin and LEAP2 levels in healthy adults and T2D patients were assessed to clarify the association of two hormones with different clinical anthropometric and metabolic parameters. Design: A total of 16 females and 40 males, ages 23–68 years old normal (n = 27), and T2D patients (n = 29) were enrolled as a cross-sectional cohort. Results: Serum levels of ghrelin were lower but serum levels of LEAP2 were higher in T2D patients. Ghrelin levels were positively correlated with fasting serum insulin levels and HOMA-IR in healthy adults. LEAP2 levels were positively correlated with age and hemoglobin A1c (HbA1c) in all tested samples. Ghrelin/LEAP2 ratio was negatively correlated with age, fasting blood glucose, and HbA1c. Conclusions: This study demonstrated a decrease in serum ghrelin levels and an increase in serum LEAP2 levels in T2D patients. LEAP2 levels were positively correlated with HbA1c, suggesting that LEAP2 was associated with T2D development. The ghrelin/LEAP2 ratio was closely associated with glycemic control in T2D patients showing a negative correlation with glucose and HbA1c.

8 May 2020 in SN Comprehensive Clinical Medicine
Verified
Journal Article
Closed access
PDF file
TMTianqi Ma
Tianqi Ma
QCQingmei Cheng
Qingmei Cheng
CCChen Chen
Chen Chen
ZLZiqiang Luo
Ziqiang Luo
DFDandan Feng
Dandan Feng

9 May 2017 in Biology of Reproduction
Verified
Journal Article
Closed access
PDF file
XHXiao-Ting Huang
Xiao-Ting Huang
SYShao-Jie Yue
Shao-Jie Yue
CLChen Li
Chen Li
JGJia Guo
Jia Guo
YHYan-Hong Huang
Yan-Hong Huang
ZLZiqiang Luo
Ziqiang Luo
Summary Sentence. The excessive activation of NMDARs is involved in the restriction of fetal pancreas development induced by intrauterine hypoxia, and antenata

1 August 2019 in Respiratory Physiology & Neurobiology
Verified
Journal Article
Closed access
LFLijuan Fang
Lijuan Fang
QCQingmei Cheng
Qingmei Cheng
FZFeiyan Zhao
Feiyan Zhao
HCHaipeng Cheng
Haipeng Cheng
YLYongyu Luo
Yongyu Luo
DFDandan Feng
Dandan Feng